Sphingolipids as Mediators of the Markers of Kidney Function/Heart Failure Association: The Multi-Ethnic Study of Atherosclerosis

BACKGROUND: Heart failure is a common complication of CKD. Sphingolipids, including ceramides and sphingomyelins, are lipid molecules with regulatory and signaling properties. Sphingolipids associated with kidney function and incident heart failure. We previously demonstrated that sphingolipids partially mediate the association between kidney function and incident heart failure. We sought to confirm this finding in the Multi-Ethnic Study of Atherosclerosis. METHODS: All sphingolipids were measured at baseline using tandem-mass spectrometry. Baseline kidney function was assessed using albuminuria and estimated glomerular filtration rate (eGFR). Associations of albuminuria and eGFR with heart failure were tested by Cox and Weibull regressions. We tested the mediation effect of sphingolipids on the associations of eGFR and albuminuria with heart failure via quasi-Bayesian Monte Carlo method based on normal approximation with 2,000 simulations. Analyses tested Bonferroni-corrected p-values 0.00625 (0.05/8 sphingolipids). RESULTS: Among 3,959 participants, the mean (SD) eGFR was 95 (17) mL/min/1.73 m2, and median (Q1, Q3) albuminuria was 5.10 (3.20, 10.2) mg/g creatinine. We observed 438 incident heart failure events over a median (Q1, Q3) follow-up of 18.9 (15.0, 19.6) years. Greater ceramide and sphingomyelin 16:0 and lesser sphingomyelin 20:0 were associated with higher heart failure risk. Sphingomyelin 16:0 was associated with partial 9%, 95% CI 3%, 30%) mediation of the association between eGFR and heart failure, and 4% (1%, 9%) mediation of the association between albuminuria and heart failure. Sphingomyelin 20:0 partially mediated the eGFR/heart failure association (6%, 95% CI 1%, 21% of association mediated). CONCLUSIONS: Plasma sphingomyelins were associated with partial mediation of the associations of eGFR and albuminuria with incident heart failure.

Authors

Institutions

Publication Details

Journal
Kidney360
Published
2026-11-13
DOI
https://doi.org/10.34067/kid.0000001429
Primary Topic
Sphingolipid Metabolism and Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sphingolipids as Mediators of the Markers of Kidney Function/Heart Failure Association: The Multi-Ethnic Study of Atherosclerosis

Nona Sotoodehnia, Rozenn N. Lemaître, Amanda M. Fretts, David S. Siscovick et al.
3 links
Kidney360
Sphingolipid Metabolism and Signaling
article

Sphingolipids as Mediators of the Markers of Kidney Function/Heart Failure Association: The Multi-Ethnic Study of Atherosclerosis

Nona Sotoodehnia, Rozenn N. Lemaître, Amanda M. Fretts, David S. Siscovick, Leila R. Zelnick, Andrew N. Hoofnagle, Ian H. de Boer, Benjamin Lidgard, Jason G. Umans, Paul N. Jensen
article en

Abstract

BACKGROUND: Heart failure is a common complication of CKD. Sphingolipids, including ceramides and sphingomyelins, are lipid molecules with regulatory and signaling properties. Sphingolipids associated with kidney function and incident heart failure. We previously demonstrated that sphingolipids partially mediate the association between kidney function and incident heart failure. We sought to confirm this finding in the Multi-Ethnic Study of Atherosclerosis. METHODS: All sphingolipids were measured at baseline using tandem-mass spectrometry. Baseline kidney function was assessed using albuminuria and estimated glomerular filtration rate (eGFR). Associations of albuminuria and eGFR with heart failure were tested by Cox and Weibull regressions. We tested the mediation effect of sphingolipids on the associations of eGFR and albuminuria with heart failure via quasi-Bayesian Monte Carlo method based on normal approximation with 2,000 simulations. Analyses tested Bonferroni-corrected p-values 0.00625 (0.05/8 sphingolipids). RESULTS: Among 3,959 participants, the mean (SD) eGFR was 95 (17) mL/min/1.73 m2, and median (Q1, Q3) albuminuria was 5.10 (3.20, 10.2) mg/g creatinine. We observed 438 incident heart failure events over a median (Q1, Q3) follow-up of 18.9 (15.0, 19.6) years. Greater ceramide and sphingomyelin 16:0 and lesser sphingomyelin 20:0 were associated with higher heart failure risk. Sphingomyelin 16:0 was associated with partial 9%, 95% CI 3%, 30%) mediation of the association between eGFR and heart failure, and 4% (1%, 9%) mediation of the association between albuminuria and heart failure. Sphingomyelin 20:0 partially mediated the eGFR/heart failure association (6%, 95% CI 1%, 21% of association mediated). CONCLUSIONS: Plasma sphingomyelins were associated with partial mediation of the associations of eGFR and albuminuria with incident heart failure.

Kidney360
New York Academy of Medicine (US), Georgetown University (US), University of Washington (US)
Good health and well-being
Sphingolipid Metabolism and Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon